Skip to main content
Clinical Trials/CTRI/2016/12/007573
CTRI/2016/12/007573
Completed
未知

Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types. - Nil

ITC Life Sciences and Technology Centre0 sites24 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ITC Life Sciences and Technology Centre
Enrollment
24
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ITC Life Sciences and Technology Centre

Eligibility Criteria

Inclusion Criteria

  • 1\) Subjects in the age group 18 \- 55 years (both the ages inclusive).
  • 2\) Healthy male and female subjects.
  • 3\)Subjects with Fitzpatrick skin type III to V.
  • 4\) Subjects willing to give a written informed consent.
  • 5\)Subjects willing to maintain the patch test in position for 24 hours.
  • 6\)Subject having not participated in a similar investigation in the past two weeks.
  • 7\)Subjects willing to come for regular follow up visits.
  • 8\)Subjects ready to follow instructions during the study period.

Exclusion Criteria

  • 1\)Infection, allergy on the tested area.
  • 2\)Skin allergy antecedents or atopic subjects.
  • 3\)Athletes and subjects with history of excessive sweating.
  • 4\)Cutaneous disease which may influence the study result.
  • 5\)Subjects on oral corticosteroid.
  • 6\)Subjects participating in any other cosmetic or therapeutic study.
  • 7\)Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials